The device, a method for treatment of high-intensity oncologic and neuropathic pain including pain resistant to morphine and other drugs, is being manufactured by CTT licensee GEOMC Co., Ltd. of Korea for worldwide distribution.We believe we are moving in the right direction toward restoring profitability, with several factors contributing to our improving financial picture.